Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))
{"title":"Dépistage des cancers du sein","authors":"Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))","doi":"10.1016/j.actpha.2024.09.036","DOIUrl":"10.1016/j.actpha.2024.09.036","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 59-61"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Damien Malbos (Docteur en pharmacie) , André Nguyen (Pharmacien, coordinateur général Coreadd Nouvelle-Aquitaine)
{"title":"Médicaments de substitution aux opioïdes, un enjeu de santé publique","authors":"Damien Malbos (Docteur en pharmacie) , André Nguyen (Pharmacien, coordinateur général Coreadd Nouvelle-Aquitaine)","doi":"10.1016/j.actpha.2024.09.034","DOIUrl":"10.1016/j.actpha.2024.09.034","url":null,"abstract":"<div><div>Les médicaments de substitution aux opioïdes, commercialisés en France depuis 1996 et remboursés par l’Assurance maladie, s’inscrivent dans l’accompagnement médical, psychologique et social des patients dépendants aux opioïdes. Initialement utilisés dans le traitement de la dépendance à l’héroïne, ils sont désormais aussi employés dans la prise en charge des dépendances à tous types d’opioïdes.</div></div><div><div>Opioid substitution drugs, marketed in France since 1996 and reimbursed by the national health insurance scheme, are part of the medical, psychological and social treatment of opioid-dependent patients. Initially used to treat heroin dependence, they are now also used to treat dependence on all types of opioids.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 49-53"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samuel Legeay (Maître de conférences des universités), Sébastien Faure (Professeur des universités)
{"title":"Cartéolol et formotérol/salbutamol","authors":"Samuel Legeay (Maître de conférences des universités), Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2024.09.024","DOIUrl":"10.1016/j.actpha.2024.09.024","url":null,"abstract":"<div><div>Une initiation de traitement par un β-bloquant non cardiosélectif tel que le cartéolol doit systématiquement faire l’objet d’une recherche d’antécédents d’asthme. Ce type de médicament, même administré par voie oculaire, peut induire une exacerbation de l’asthme. Le pharmacien d’officine doit refuser la délivrance chez les patients asthmatiques ou ayant des antécédents d’asthme, et proposer au médecin prescripteur une alternative.</div></div><div><div>When initiating treatment with a non-cardioselective β-blocker such as kateolol, a history of asthma should always be sought. This type of drug, even when administered via the ocular route, can induce asthma exacerbation. The dispensing pharmacist must refuse to dispense to patients with asthma or a history of asthma, and suggest an alternative to the prescribing physician.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 13-15"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prise en charge de la cystite à l’officine, du Trod à la délivrance de l’antibiothérapie","authors":"Anne-Solène Naudon (Docteure en pharmacie)","doi":"10.1016/j.actpha.2024.09.032","DOIUrl":"10.1016/j.actpha.2024.09.032","url":null,"abstract":"<div><div>La cystite aiguë est une affection fréquente chez la femme. Les pharmaciens peuvent dorénavant prescrire et délivrer des antibiotiques en cas de test rapide d’orientation diagnostique positif sous certaines conditions. Ce changement renforce leur rôle dans le système de santé, en offrant des soins de proximité accessibles tout en optimisant la prise en charge des patientes.</div></div><div><div>Acute cystitis is a frequent complaint in women. Pharmacists can now prescribe and dispense antibiotics in the event of a positive rapid diagnostic test, under certain conditions. This change reinforces their role in the healthcare system, offering local accessible care while optimizing patient care.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 42-44"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Les idées reçues sur l’activité physique et sportive","authors":"Peggy André (Docteure en pharmacie)","doi":"10.1016/j.actpha.2024.09.035","DOIUrl":"10.1016/j.actpha.2024.09.035","url":null,"abstract":"<div><div>Chacun a un avis, plus ou moins étayé, sur l’intérêt, les bénéfices et les dangers du sport. Le pharmacien doit être à même de déployer des arguments validés face aux idées reçues souvent rapportées par la patientèle, notamment sur les liens entre l’activité sportive et la santé.</div></div><div><div>Everyone has an opinion, more or less well-founded, on the benefits and dangers of sport. Pharmacists need to be able to put forward validated arguments in the face of preconceived ideas often reported by their patients, particularly concerning the links between sporting activity and health.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 54-58"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laurent Misery (Professeur des universités, praticien hospitalier)
{"title":"La peau sensible","authors":"Laurent Misery (Professeur des universités, praticien hospitalier)","doi":"10.1016/j.actpha.2024.09.030","DOIUrl":"10.1016/j.actpha.2024.09.030","url":null,"abstract":"<div><div>Une peau sensible, ou réactive, se définit par la survenue de sensations déplaisantes. Très fréquente, elle correspond à une réactivité anormale de la peau dont le seuil de tolérance est abaissé. Les mécanismes sont mal connus mais une atteinte des terminaisons nerveuses apparaît de plus en plus clairement comme le facteur principal. La peau sensible serait liée à une libération excessive de cytokines et de neuromédiateurs en réponse à une hyperactivation de protéines sensorielles, donc surtout à une hyperexcitabilité du système nerveux cutané.</div></div><div><div>Sensitive or reactive skin is defined by the occurrence of unpleasant sensations. Very common, it corresponds to an abnormal reactivity of the skin, whose tolerance threshold is lowered. The mechanisms are poorly understood, but damage to nerve endings is emerging as the main factor. Sensitive skin is thought to be linked to excessive release of cytokines and neurotransmitters in response to hyperactivation of sensory proteins, and therefore above all to hyperexcitability of the cutaneous nervous system.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 35-37"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))
{"title":"Détection et accompagnement d’une dysphagie","authors":"Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))","doi":"10.1016/j.actpha.2024.09.033","DOIUrl":"10.1016/j.actpha.2024.09.033","url":null,"abstract":"<div><div>La dysphagie est un trouble de la déglutition qui a une étiologie variable et des conséquences parfois mortelles. Le pharmacien est en première ligne pour le détecter et accompagner les personnes qui en souffrent.</div></div><div><div>Dysphagia is a swallowing disorder with variable etiology and sometimes fatal consequences. Pharmacists are on the front line in detecting it and supporting sufferers.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Pages 45-48"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cosmétiques et prise en charge globale du patient, une opportunité pour l’officine","authors":"Laurence Coiffard (Professeure des universités)","doi":"10.1016/j.actpha.2024.09.025","DOIUrl":"10.1016/j.actpha.2024.09.025","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 641","pages":"Page 17"},"PeriodicalIF":0.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
